These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 31677889

  • 1. Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD.
    Coccia F, Testa M, Guarisco G, Di Cristofano C, Silecchia G, Leonetti F, Gastaldelli A, Capoccia D.
    Nutr Metab Cardiovasc Dis; 2020 Jan 03; 30(1):106-113. PubMed ID: 31677889
    [Abstract] [Full Text] [Related]

  • 2. Noninvasive assessment of hepatic steatosis and fibrosis in patients with severe obesity.
    Coccia F, Testa M, Guarisco G, Bonci E, Di Cristofano C, Silecchia G, Leonetti F, Gastaldelli A, Capoccia D.
    Endocrine; 2020 Mar 03; 67(3):569-578. PubMed ID: 31858390
    [Abstract] [Full Text] [Related]

  • 3. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L, Di Martino M, Anania C, Andreoli GM, Bezzi M, Catalano C, Chiesa C.
    World J Gastroenterol; 2015 Apr 21; 21(15):4688-95. PubMed ID: 25914480
    [Abstract] [Full Text] [Related]

  • 4. Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features.
    Cazzo E, Jimenez LS, Gestic MA, Utrini MP, Chaim FHM, Chaim FDM, Pareja JC, Chaim EA.
    Obes Surg; 2018 Jan 21; 28(1):187-194. PubMed ID: 28741239
    [Abstract] [Full Text] [Related]

  • 5. Insulin Resistance, but Not Obstructive Sleep Apnea Is Associated with Hepatic Steatosis in Chinese Patients with Severe Obesity.
    Zhu C, Tang S, Xiao J, Zhang Y, Sun L, Zhang J, Ding L, Liu M.
    Obes Facts; 2023 Jan 21; 16(4):344-355. PubMed ID: 36854279
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms for increased risk of diabetes in chronic liver diseases.
    Svegliati-Baroni G, Gaggini M, Carli F, Barbieri C, Cucco M, Youne R, Rosso C, Bugianesi E, Gastaldelli A.
    Liver Int; 2020 Oct 21; 40(10):2489-2499. PubMed ID: 32515880
    [Abstract] [Full Text] [Related]

  • 7. Significance of oral glucose tolerance tests in non-alcoholic fatty liver disease patients with a fasting plasma glucose level of <126 mg/dL and HbA1c level of ≤ 6.4% in Japan.
    Matsumoto N, Arase Y, Kawamura Y, Ohmoto-Sekine M, Amakawa K, Ogawa K, Tsuji H, Dong HS, Hara S, Akuta N, Suzuki F, Suzuki Y, Ikeda K, Kumada H, Kobayashi T.
    Intern Med; 2015 Oct 21; 54(8):875-80. PubMed ID: 25876566
    [Abstract] [Full Text] [Related]

  • 8. Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease.
    Nascimbeni F, Bedossa P, Fedchuk L, Pais R, Charlotte F, Lebray P, Poynard T, Ratziu V, LIDO (Liver Injury in Diabetes and Obesity) Study Group.
    J Hepatol; 2020 May 21; 72(5):828-838. PubMed ID: 31862486
    [Abstract] [Full Text] [Related]

  • 9. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N, Beltrán-Debón R, Rodríguez-Gallego E, Hernández-Aguilera A, Guirro M, Mariné-Casadó R, Millá L, Alegret JM, Sabench F, del Castillo D, Vinaixa M, Rodríguez MÀ, Correig X, García-Álvarez R, Menendez JA, Camps J, Joven J.
    World J Gastroenterol; 2015 Jun 28; 21(24):7529-44. PubMed ID: 26140000
    [Abstract] [Full Text] [Related]

  • 10. Insulin sensitivity indices: fasting versus glucose-stimulated ındices in pediatric non-alcoholic fatty liver disease.
    Ozhan B, Ersoy B, Kiremitci S, Ozkol M, Taneli F.
    Eur Rev Med Pharmacol Sci; 2015 Sep 28; 19(18):3450-8. PubMed ID: 26439042
    [Abstract] [Full Text] [Related]

  • 11. Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis.
    Chatterjee A, Basu A, Das K, Singh P, Mondal D, Bhattacharya B, Roychoudhury S, Majumder PP, Chowdhury A, Basu P.
    Ann Hepatol; 2020 Sep 28; 19(5):472-481. PubMed ID: 32682086
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
    Jung KY, Cho SY, Kim HJ, Kim SB, Song IH.
    J Clin Gastroenterol; 2014 Sep 28; 48(10):883-8. PubMed ID: 24440936
    [Abstract] [Full Text] [Related]

  • 15. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H, Zhu X, Xia M, Yan H, Chang X, Hu X, Pan B, Guo W, Li X, Gao X.
    Endocr Pract; 2020 Apr 28; 26(4):444-453. PubMed ID: 31968197
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring.
    Oki Y, Ono M, Hyogo H, Ochi T, Munekage K, Nozaki Y, Hirose A, Masuda K, Mizuta H, Okamoto N, Saibara T.
    Eur J Gastroenterol Hepatol; 2018 Jul 28; 30(7):797-805. PubMed ID: 29634665
    [Abstract] [Full Text] [Related]

  • 17. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo Sanchez P, Bril F, Maximos M, Lomonaco R, Biernacki D, Orsak B, Subbarayan S, Webb A, Hecht J, Cusi K.
    J Clin Endocrinol Metab; 2014 Oct 10; 100(5):. PubMed ID: 25303488
    [Abstract] [Full Text] [Related]

  • 18. Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.
    Liew PL, Lee WJ, Wang W, Lee YC, Chen WY, Fang CL, Huang MT.
    Obes Surg; 2008 Jul 10; 18(7):847-53. PubMed ID: 18459024
    [Abstract] [Full Text] [Related]

  • 19. Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.
    Sterling RK, Smith PG, Brunt EM.
    J Clin Gastroenterol; 2013 Feb 10; 47(2):182-7. PubMed ID: 23059409
    [Abstract] [Full Text] [Related]

  • 20. Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.
    Kalavalapalli S, Leiva EG, Lomonaco R, Chi X, Shrestha S, Dillard R, Budd J, Romero JP, Li C, Bril F, Samraj G, Pennington J, Townsend P, Orlando F, Shetty S, Mansour L, Silva-Sombra LR, Bedossa P, Malaty J, Barb D, Gurka MJ, Cusi K.
    J Clin Endocrinol Metab; 2023 Apr 13; 108(5):1192-1201. PubMed ID: 36378995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.